Diagnostic activity impacts lifetime risk of prostate cancer diagnosis more strongly than life expectancy. Orrason AW, Westerberg M, Albertsen P, Styrke J, et al. PLoS One 2022;17:e0277784.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Orrason AW, Westerberg M, Albertsen P, Styrke J, et al. Diagnostic activity impacts lifetime risk of prostate cancer diagnosis more strongly than life expectancy. PLoS One 2022;17:e0277784.
PMID: 36417412